Is it time to buy UBER stock? Uber Technologies (NYSE:UBER) seems to be on a roll. Despite the disruption the emergence of the COVID-19 caused in the transportation marketplace, UBER seems to be snapping back. During the company’s most recent quarterly earnings call, CEO Dara Khosrowshah stated that the company had achieved total adjusted EBITDA profitability for the second quarter in a row –
When searching for the next great dividend stock to invest in, International Paper isn’t at the top of most investors’ lists, but maybe it should be.
While it might not be a household name with a hot new product on the market or some groundbreaking developer of an innovative medical treatment, International Paper offers a dividend that is not to be scoffed at — the company’s numbers speak for themselves in this instance.
You’ve heard of the phrase “don’t put all your eggs in one basket,” but what about all your apples? For the past ten years, that’s exactly what tech giant Apple has been doing. With nearly 200 billion in cash on hand, the company has spent over half a trillion dollars in the last decade doling out dividends and buying back its own stock without fail.
» Read more about: Half A Trillion Dollars Invested In 1 Stock »
In response to the COVID pandemic, health care companies are high on investors’ radars. After a breakout from a three-year consolidation pattern, Cardinal Health stock is worth paying attention to, especially since the company is a quality, well-established business. Moreover, Cardinal Health (NYSE:CAH) is arguably among the most undervalued health stocks today. But first,
» Read more about: The Most Undervalued Health Stock Right Now »
Just a few months ago, shares of Chinese e-commerce giant Alibaba (NYSE:BABA) plunged by 22.7 percent over the course of the month. The company had lost approximately 45 percent of its value over a one year period. These losses contrast sharply with Alibaba’s fundamentals, which are generally quite positive.
Berkshire Hathaway (BRK.A) stock price is among the most expensive in the world, yet the company’s valuation arguably leaves a lot of room to the upside still. While Cathie Wood’s ARK was stealing headlines over the past couple of years for her disruptive innovation thematic investments, Berkshire Hathaway share price crept up quietly to ultimately outperform ARKK over the past 2 years.
» Read more about: Will Berkshire Be a $1 Trillion Company? »
The impact of a sleep deficit goes far beyond feeling a bit drowsy during the day. Getting less than seven hours of sleep regularly can contribute to weight gain and obesity, high blood pressure, diabetes, stroke and heart disease. Lack of sleep is also associated with depression, reduced immune function, increased pain, more errors, more accidents and impaired performance at work or school.
When Meta — the company formerly known as Facebook — announced its intent to transition its attention away from social media and toward the Metaverse, this massive shift in focus immediately grabbed the attention of retail investors and traders alike. Hoping to get in on the ground level of this buzzworthy new iteration of the Internet,
» Read more about: The ONLY Metaverse Stock To Own For 10 Years »
Shares of electronic signature software provider DocuSign (NASDAQ:DOCU) tumbled by a remarkable 42 percent following the company’s Q3 report. The massive selloff eradicated nearly $20 billion in overall value. Since the the stock has lost another 15% in value. However, following this shock, many investors are wondering whether DocuSign could now be undervalued.
Traders looking to invest in vaccine stocks faced a difficult decision at the start of the vaccine rollout in late 2020 and early 2021: which vaccine stock would be the best bet in the months and years to come? With Pfizer and BioNTech, Johnson & Johnson and Moderna all becoming available at once, there was no way to know for sure which investment would yield the greatest returns.
